Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Paul F. Cook, Sarah J. Schmiege, Steven L. Mansberger, Christina Sheppler, Jeffrey Kammer, Timothy Fitzgerald & Malik Y. Kahook. (2017) Motivational interviewing or reminders for glaucoma medication adherence: Results of a multi-site randomised controlled trial. Psychology & Health 32:2, pages 145-165.
Read now
Read now
Jordana K Schmier, Carolyn K Hulme-Lowe & David W Covert. (2014) Adjunctive therapy patterns in glaucoma patients using prostaglandin analogs. Clinical Ophthalmology 8, pages 1097-1104.
Read now
Read now
Susana Murteira, Zied Ghezaiel, Slim Karray & Michel Lamure. (2013) Drug reformulations and repositioning in pharmaceutical industry and its impact on market access: reassessment of nomenclature. Journal of Market Access & Health Policy 1:1.
Read now
Read now
Jordana K Schmier & David W Covert. (2010) First-year treatment costs among new initiators of topical prostaglandin analogs: pooled results. Clinical Ophthalmology 4, pages 437-445.
Read now
Read now
Jordana K Schmier, Edmund C Lau & David W Covert. (2010) Two-year treatment patterns and costs in glaucoma patients initiating treatment with prostaglandin analogs. Clinical Ophthalmology 4, pages 1137-1143.
Read now
Read now
Jordana K. Schmier, David W. Covert & Alan L. Robin. (2010) First-year treatment costs among new initiators of topical prostaglandin analog identified from November 2007 through April 2008. Current Medical Research and Opinion 26:12, pages 2769-2777.
Read now
Read now
Jordana K Schmier & David W Covert. (2009) Characteristics of respondents with glaucoma and dry eye in a national panel survey. Clinical Ophthalmology 3, pages 645-650.
Read now
Read now
Jordana K Schmier, David W Covert & Alan L Robin. (2009) First-year treatment costs among new initiators of topical prostaglandin analogs. Clinical Ophthalmology 3, pages 637-644.
Read now
Read now
Articles from other publishers (11)
Gail F. Schwartz, Anik Patel, Rupali Naik, Orsolya Lunacsek, Augustina Ogbonnaya & Joanna Campbell. (2021) Characteristics and Treatment Patterns of Newly Diagnosed Open-Angle Glaucoma Patients in the United States. Ophthalmology Glaucoma 4:2, pages 117-125.
Crossref
Crossref
Robyn Sayner, Delesha M. Carpenter, Susan J. Blalock, Alan L. Robin, Kelly W. Muir, Mary Elizabeth Hartnett, Annette L. Giangiacomo, Gail Tudor & Betsy Sleath. (2015) Accuracy of Patient-reported Adherence to Glaucoma Medications on a Visual Analog Scale Compared With Electronic Monitors. Clinical Therapeutics 37:9, pages 1975-1985.
Crossref
Crossref
Paul F. Cook, Sarah J. Schmiege, Steven L. Mansberger, Jeffrey Kammer, Timothy Fitzgerald & Malik Y. Kahook. (2014) Predictors of Adherence to Glaucoma Treatment in a Multisite Study. Annals of Behavioral Medicine 49:1, pages 29-39.
Crossref
Crossref
Murat Irkec, Banu Bozkurt & Mehmet Cem Mocan. (2013) Are preservatives necessary to improve efficacy of some glaucoma drops?. British Journal of Ophthalmology 97:12, pages 1493-1494.
Crossref
Crossref
Laura E. Dreer, Christopher A. Girkin, Lisa Campbell, Andy Wood, Liyan Gao & Cynthia Owsley. (2013) Glaucoma Medication Adherence among African Americans. Optometry and Vision Science 90:8, pages 883-897.
Crossref
Crossref
Paul Cook, Sarah Schmiege, Margaret McClean, Laurra Aagaard & Malik Kahook. (2011) Practical and Analytic Issues in the Electronic Assessment of Adherence. Western Journal of Nursing Research 34:5, pages 598-620.
Crossref
Crossref
Françoise Brignole-BaudouinLuisa RianchoHong LiangZaki NakibChristophe Baudouin. (2011)
In Vitro
Comparative Toxicology of Polyquad-Preserved and Benzalkonium Chloride-Preserved Travoprost/Timolol Fixed Combination and Latanoprost/Timolol Fixed Combination
. Journal of Ocular Pharmacology and Therapeutics 27:3, pages 273-280.
Crossref
Crossref
Hong Liang, Françoise Brignole-Baudouin, Aude Pauly, Luisa Riancho & Christophe Baudouin. (2011) Polyquad-preserved travoprost/timolol, benzalkonium chloride (BAK)-preserved travoprost/timolol, and latanoprost/timolol in fixed combinations: a rabbit ocular surface study. Advances in Therapy 28:4, pages 311-325.
Crossref
Crossref
. (2011) Current World Literature. Current Opinion in Ophthalmology 22:2, pages 141-146.
Crossref
Crossref
Anja Tuulonen. (2011) Economic considerations of the diagnosis and management for glaucoma in the developed world. Current Opinion in Ophthalmology 22:2, pages 102-109.
Crossref
Crossref
Vicky H. Lu, Ivan Goldberg & Christine Y. Lu. (2010) Use of Glaucoma Medications: State of the Science and Directions for Observational Research. American Journal of Ophthalmology 150:4, pages 569-574.e9.
Crossref
Crossref